Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IGA Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07522099
What this trial is testing

Chinese Adults With Kidney Disease

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)Complement 3 Glomerulopathy (C3G)IC-MPGN
ADARx Pharmaceuticals, Inc. 30
Not applicableStudy completedNCT00301613
What this trial is testing

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

Who this might be right for
Henoch-Schoenlein PurpuraNephritis
Nanjing University School of Medicine 60
Early research (Phase 1)Study completedNCT03719443
What this trial is testing

First in Human Study to Assess Safety of VIS649 in Healthy Subjects

Who this might be right for
Immunoglobulin A NephropathyIgAN - IgA NephropathyIgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 51
Testing effectiveness (Phase 2)Ended earlyNCT04905212
What this trial is testing

Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy

Who this might be right for
IgA Nephropathy
RemeGen Co., Ltd. 15
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Not applicableEnded earlyNCT00885547
What this trial is testing

Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553494
What this trial is testing

SLN12140 in Adult Participants With IgA Nephropathy in China

Who this might be right for
IgA Nephropathy (IgAN)
Linno Pharmaceuticals, Inc. 48
Not applicableStudy completedNCT01775527
What this trial is testing

IgA Nephropathy, Lymphocyte Homing and IgA Class Switch

Who this might be right for
IgA Nephropathy
University Hospital, Limoges 72
Large-scale testing (Phase 3)Looking for participantsNCT05510323
What this trial is testing

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

Who this might be right for
Glomerulonephritis, IGA
Air Force Military Medical University, China 208
Not applicableLooking for participantsNCT06926244
What this trial is testing

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

Who this might be right for
IgA Nephropathy (IgAN)
Assistance Publique - Hôpitaux de Paris 800
Not applicableUnknownNCT01203007
What this trial is testing

Diet Intervention in Food Sensitive Patients With IgA Nephropathy

Who this might be right for
IGA Nephropathy
Uppsala University Hospital 40
Post-approval studies (Phase 4)Looking for participantsNCT06712407
What this trial is testing

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

Who this might be right for
IgA Nephropathy
Calliditas Therapeutics AB 60
Post-approval studies (Phase 4)Looking for participantsNCT07604311
What this trial is testing

Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Nanfang Hospital, Southern Medical University 288
Not applicableStudy completedNCT01538433
What this trial is testing

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Guangdong Provincial People's Hospital 603
Post-approval studies (Phase 4)Looking for participantsNCT06676384
What this trial is testing

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Who this might be right for
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India 585
Early research (Phase 1)Study completedNCT04887532
What this trial is testing

A Trial of HR19042 Capsule in Healthy Chinese Subjects

Who this might be right for
Primary IgA Nephropathy
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Testing effectiveness (Phase 2)Ended earlyNCT04042623
What this trial is testing

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Aravive, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT05856760
What this trial is testing

Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

Who this might be right for
Immunoglobulin A Nephropathy
Travere Therapeutics, Inc. 48
Post-approval studies (Phase 4)Looking for participantsNCT07030894
What this trial is testing

Nefecon and Ambrisentan in IgA Nephropathy

Who this might be right for
IgA NephropathyChronic Kidney DiseaseProteinuria
The First Hospital of Jilin University 129
Next Page